Skip to main content
lexblog.com/lib/XG7KV4WBviewrecordjson
LEX-WK-XG7KV4WBcrawled 2022-12-01 10:07Z

Failure-to-Warn Claim Targeting Branded Drug Held Preempted:  Litigation-Driven Expert Analysis Is Not “Newly Acquired Information” for Purposes of the “Changes Being Effected” Regulation

Andrew Tauber · Drug & Device Law · Published September 19, 2022

Work details

practice area
Other
published
2022-09-19

Citation

Andrew Tauber, Failure-to-Warn Claim Targeting Branded Drug Held Preempted:  Litigation-Driven Expert Analysis Is Not “Newly Acquired Information” for Purposes of the “Changes Being Effected” Regulation, Drug & Device Law (September 19, 2022) [The Library at LexBlog, LEX-WK-XG7KV4WB, lexpid.org/XG7KV4WB]